BioLineRx Announces Initiation of BL-8040, Keytruda and Chemotherapy Combination Arm in the Phase 2a COMBAT/KEYNOTE-202 Pancreatic Cancer Trial – CBI
Homepage /  Press Release /  BioLineRx Announces Initiation of BL-8040, Keytruda and Chemotherapy Combination Arm in the Phase 2a COMBAT/KEYNOTE-202 Pancreatic Cancer Trial

Press Release

BioLineRx Announces Initiation of BL-8040, Keytruda and Chemotherapy Combination Arm in the Phase 2a COMBAT/KEYNOTE-202 Pancreatic Cancer Trial